Have a personal or library account? Click to login
Splenic Metastasis in Ewing Sarcoma Cover
Open Access
|Feb 2026

Figures & Tables

jbsr-110-1-4203-g1.png
Figure 1

Primary diagnosis.

(a, b) Abdominal CT. An irregular sclerotic lesion in hemicorpus L5, with extensive associated paravertebral soft tissue involvement (5.5 × 6.5 × 6.0 cm) (arrows).

(c, d) Spinal MRI. A T2‑hyperintense, heterogeneously contrast‑enhancing mass in hemicorpus L5, with associated soft tissue involvement extending into the intervertebral foramen L4‑L5 (arrow).

jbsr-110-1-4203-g2.png
Figure 2

Splenic metastasis.

(a, b) Abdominal CT. A sharply defined mass (5.5 × 7.2 × 5.8 cm), globally hypodense and inhomogeneously contrast‑enhancing, located cranially and subcapsular in the spleen. Notice the bulging of the diaphragm (arrows), without signs of pleural/pulmonary invasion.

(c, d) Abdominal US. A sharply defined, heterogeneous mass (5.5 × 7.2 cm) located cranially and subcapsular in the spleen. Colour Doppler shows present yet not pronounced vascularization.

jbsr-110-1-4203-g3.png
Figure 3

Macroscopic pathological examination of the spleen.

jbsr-110-1-4203-g4.png
Figure 4

Microscopic pathological examination of the spleen.

(a, b) Haematoxylin and eosin staining of a splenectomy specimen. The splenic tissue is diffusely invaded by small round blue cells and necrosis. Notice the fibrotic islands with surrounding characteristic cells.

(c) Immunohistochemical staining of the splenectomy specimen. Strong, diffuse positivity for CD99 in a honeycomb pattern, correlating with high membranous expression typical for Ewing sarcoma.

DOI: https://doi.org/10.5334/jbsr.4203 | Journal eISSN: 2514-8281
Language: English
Submitted on: Dec 30, 2025
|
Accepted on: Jan 5, 2026
|
Published on: Feb 5, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Lucas Bijnens, Brecht Van Berkel, Maarten Steyvers, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.